Already a DIA Member? Sign in. Not a member? Join.

Sign in

Forgot User ID? or Forgot Password?

Not a Member?

Create Account and Join

Boston Convention and Exhibition Center

Jun 23, 2013 8:30 AM - Jun 27, 2013 12:45 PM

415 Summer Street, , Boston, MA 02210 , USA

DIA 2013 49th Annual Meeting: Advancing Therapeutic Innovation and Regulatory Science

Finessing Scientifically Accurate, Comprehensible, Compliant, Clinically-focused Module 2 Summaries of an eCTD-based Submission

Session Chair(s)

Nancy  Katz, PhD

Nancy Katz, PhD

Illyria Consulting Group, Inc., United States

This forum features three speakers who will provide expert and proven strategies that enable scientifically accurate, on time, on budget eCTD-based submissions.

Learning Objective : Explain how to write for a regulator; Describe how to establish, lead, and/or support team members of an eCTD-based submission team who are writing clinically focused Module 2 summaries; Describe the deliverables required from each new team member.

Speaker(s)

Meredith  Brown-Tuttle, RAC

Memorable and Compelling Writing for eCTD Documents

Meredith Brown-Tuttle, RAC

United States

Regulatory Affairs

Nancy  Katz, PhD

The Well-Oiled Team: Playing Your Position from SAS Output Through Quality Assurance Audit to Create Reviewer-ready Regulatory Documents

Nancy Katz, PhD

Illyria Consulting Group, Inc., United States

Stephen B. Shrewsbury, MD, FFPM

The Grand Design: The Fundamental, Ongoing and Unrelenting Contribution of the Medical Monitor to the Drug Development Process

Stephen B. Shrewsbury, MD, FFPM

LifeSplice Pharma, Canada

Advisory Board

Have an account?

Be informed and stay engaged.

Don't miss an opportunity - join our mailing list to stay up to date on DIA insights and events.